Position in INBX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,186,545
New position
Shares Held
23,077
first reported quarter
Ownership
0.157%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#47
of 162 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 22%
Shared 0%
None 78%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $117,620,448 across 34 Biotechnology names. INBX ranks #22 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
49,357 | $9,243,578 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
117,987 | $6,702,841 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
26,152 | $6,401,225 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
19,498 | $6,163,122 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
16,227 | $6,031,089 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
24,544 | $5,914,367 | |
| 7 | CYTK |
Cytokinetics Inc
|
68,185 | $5,808,680 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
120,928 | $5,688,453 |
All Filings in INBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,186,545 | 23,077 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||